Insulin aspart, recombinant Subcutaneous and Pazopanib Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Pazopanib Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: pazopanib
Brand name: Votrient
Synonyms: Pazopanib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-PB Hyos Elixir
- Insulin aspart, recombinant Subcutaneous-PCE
- Insulin aspart, recombinant Subcutaneous-PCE Dispertab
- Insulin aspart, recombinant Subcutaneous-PCM-LA
- Insulin aspart, recombinant Subcutaneous-Pedia Care Multi-Symptom Cold
- Insulin aspart, recombinant Subcutaneous-Pedia Poly-Vite Drops with Iron
- Pazopanib Hydrochloride-Insulin degludec
- Pazopanib Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Pazopanib Hydrochloride-Insulin Degludec (U-100) Vials
- Pazopanib Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Pazopanib Hydrochloride-Insulin degludec and liraglutide
- Pazopanib Hydrochloride-Insulin degludec and liraglutide Subcutaneous